Hua Medicine (Shanghai) Statistics

Total Valuation

HKG:2552 has a market cap or net worth of HKD 3.37 billion. The enterprise value is 2.49 billion.

Market Cap	3.37B
Enterprise Value	2.49B

Important Dates

The last earnings date was Thursday, March 26, 2026.

Earnings Date	Mar 26, 2026
Ex-Dividend Date	n/a

Share Statistics

HKG:2552 has 996.52 million shares outstanding. The number of shares has increased by 2.33% in one year.

Current Share Class	996.52M
Shares Outstanding	996.52M
Shares Change (YoY)	+2.33%
Shares Change (QoQ)	+2.44%
Owned by Insiders (%)	5.50%
Owned by Institutions (%)	1.81%
Float	652.80M

Valuation Ratios

The trailing PE ratio is 2.76.

PE Ratio	2.76
Forward PE	n/a
PS Ratio	6.14
PB Ratio	3.01
P/TBV Ratio	3.08
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	2.02
EV / Sales	4.54
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-37.46

Financial Position

The company has a current ratio of 6.17, with a Debt / Equity ratio of 0.30.

Current Ratio	6.17
Quick Ratio	5.57
Debt / Equity	0.30
Debt / EBITDA	n/a
Debt / FCF	-5.05
Interest Coverage	-17.79

Financial Efficiency

Return on equity (ROE) is 254.05% and return on invested capital (ROIC) is -12.30%.

Return on Equity (ROE)	254.05%
Return on Assets (ROA)	-6.04%
Return on Invested Capital (ROIC)	-12.30%
Return on Capital Employed (ROCE)	-11.50%
Weighted Average Cost of Capital (WACC)	8.53%
Revenue Per Employee	1.67M
Profits Per Employee	3.75M
Employee Count	328
Asset Turnover	0.33
Inventory Turnover	1.71

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +56.48% in the last 52 weeks. The beta is 0.89, so HKG:2552's price volatility has been lower than the market average.

Beta (5Y)	0.89
52-Week Price Change	+56.48%
50-Day Moving Average	3.32
200-Day Moving Average	3.48
Relative Strength Index (RSI)	45.28
Average Volume (20 Days)	3,376,754

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:2552 had revenue of HKD 548.54 million and earned 1.23 billion in profits. Earnings per share was 1.22.

Revenue	548.54M
Gross Profit	311.98M
Operating Income	-161.23M
Pretax Income	1.23B
Net Income	1.23B
EBITDA	-146.66M
EBIT	-161.23M
Earnings Per Share (EPS)	1.22

Full Income Statement

Balance Sheet

The company has 1.22 billion in cash and 335.70 million in debt, giving a net cash position of 879.80 million or 0.88 per share.

Cash & Cash Equivalents	1.22B
Total Debt	335.70M
Net Cash	879.80M
Net Cash Per Share	0.88
Equity (Book Value)	1.12B
Book Value Per Share	1.12
Working Capital	1.21B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -58.03 million and capital expenditures -8.40 million, giving a free cash flow of -66.43 million.

Operating Cash Flow	-58.03M
Capital Expenditures	-8.40M
Depreciation & Amortization	16.42M
Net Borrowing	n/a
Free Cash Flow	-66.43M
FCF Per Share	-0.07

Full Cash Flow Statement

Margins

Gross margin is 56.87%, with operating and profit margins of -29.39% and 224.44%.

Gross Margin	56.87%
Operating Margin	-29.39%
Pretax Margin	224.44%
Profit Margin	224.44%
EBITDA Margin	-26.74%
EBIT Margin	-29.39%
FCF Margin	n/a

Dividends & Yields

HKG:2552 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.33%
Shareholder Yield	-2.33%
Earnings Yield	36.55%
FCF Yield	-1.97%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

HKG:2552 has an Altman Z-Score of -0.71 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.71
Piotroski F-Score	3